Completed PHASE4 INTERVENTIONAL 2-arm NCT00299650

Systematic Early Use of Neuromuscular Blocking Agents in ARDS Patients

Sponsor: Assistance Publique Hopitaux De Marseille

Conditions ARDS

Interventions Cisatracurium besilate Placebo cisatracurium

Updated 6 times since 2017 Last updated: Oct 9, 2008 Started: Mar 31, 2006 Primary completion: Oct 31, 2008 Completion: Oct 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on ARDS, this trial is completed. The trial is conducted by Assistance Publique Hopitaux De Marseille and has accumulated 6 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assistance Publique Hopitaux De Marseille
GlaxoSmithKline

Data source: Assistance Publique Hopitaux De Marseille

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aix-en-Provence, France , Avignon, France , Besançon, France , Bordeaux, France , Brest, France , Clermont-Ferrand, France , Grenoble, France , Lyon, France , Marseille, France , Montpellier, France and 6 more locations